314 related articles for article (PubMed ID: 26710770)
1. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
[TBL] [Abstract][Full Text] [Related]
2. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
3. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
Khan A; Mathelier A; Zhang X
Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
[TBL] [Abstract][Full Text] [Related]
4. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
[TBL] [Abstract][Full Text] [Related]
6. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.
Hnisz D; Schuijers J; Lin CY; Weintraub AS; Abraham BJ; Lee TI; Bradner JE; Young RA
Mol Cell; 2015 Apr; 58(2):362-70. PubMed ID: 25801169
[TBL] [Abstract][Full Text] [Related]
7. What are super-enhancers?
Pott S; Lieb JD
Nat Genet; 2015 Jan; 47(1):8-12. PubMed ID: 25547603
[TBL] [Abstract][Full Text] [Related]
8. The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers.
Shin HY
Genes Genomics; 2019 Mar; 41(3):257-265. PubMed ID: 30456521
[TBL] [Abstract][Full Text] [Related]
9. Super-enhancers in transcriptional regulation and genome organization.
Wang X; Cairns MJ; Yan J
Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731
[TBL] [Abstract][Full Text] [Related]
10. Identifying clusters of
Madani Tonekaboni SA; Mazrooei P; Kofia V; Haibe-Kains B; Lupien M
Genome Res; 2019 Oct; 29(10):1733-1743. PubMed ID: 31533978
[TBL] [Abstract][Full Text] [Related]
11. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice.
Adam RC; Yang H; Rockowitz S; Larsen SB; Nikolova M; Oristian DS; Polak L; Kadaja M; Asare A; Zheng D; Fuchs E
Nature; 2015 May; 521(7552):366-70. PubMed ID: 25799994
[TBL] [Abstract][Full Text] [Related]
12. A new class of constitutively active super-enhancers is associated with fast recovery of 3D chromatin loops.
Ryu J; Kim H; Yang D; Lee AJ; Jung I
BMC Bioinformatics; 2019 Mar; 20(Suppl 3):127. PubMed ID: 30925856
[TBL] [Abstract][Full Text] [Related]
13. SEA: a super-enhancer archive.
Wei Y; Zhang S; Shang S; Zhang B; Li S; Wang X; Wang F; Su J; Wu Q; Liu H; Zhang Y
Nucleic Acids Res; 2016 Jan; 44(D1):D172-9. PubMed ID: 26578594
[TBL] [Abstract][Full Text] [Related]
14. Super-Enhancers Dysregulations in Hematological Malignancies.
Belloucif Y; Lobry C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
[TBL] [Abstract][Full Text] [Related]
15. Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
Ko JY; Oh S; Yoo KH
Mol Cells; 2017 Mar; 40(3):169-177. PubMed ID: 28359147
[TBL] [Abstract][Full Text] [Related]
16. Mapping the evolving landscape of super-enhancers during cell differentiation.
Kai Y; Li BE; Zhu M; Li GY; Chen F; Han Y; Cha HJ; Orkin SH; Cai W; Huang J; Yuan GC
Genome Biol; 2021 Sep; 22(1):269. PubMed ID: 34526084
[TBL] [Abstract][Full Text] [Related]
17. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
18. Super-lncRNAs: identification of lncRNAs that target super-enhancers via RNA:DNA:DNA triplex formation.
Soibam B
RNA; 2017 Nov; 23(11):1729-1742. PubMed ID: 28839111
[TBL] [Abstract][Full Text] [Related]
19. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
20. Super-enhancer lncs to cardiovascular development and disease.
Ounzain S; Pedrazzini T
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1953-60. PubMed ID: 26620798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
